Fat jabs BOOST survival of killer cancer surging among the young – drug may ‘slash risk of death by 50%’

WEIGHT loss jabs may boost survival for people with head and neck cancer, slashing risk of death by 50 per cent, new research shows.

Rates of the disease among young people are rising – especially among younger people.

Hand in a blue glove holding an Ozempic insulin injection pen.
Weight loss jabs could improve survival for people with head and neck cancer Source: Getty
Illustration showing how fat jabs work: injection, hunger suppression, slower stomach emptying, and weight loss.

Throat cancer diagnoses in England rose 47 per cent between 2013 and 2020, research from the University of Sheffield recently showed.

But head and neck cancer still remains more common in older adults, affecting 13,800 people in the UK each year.

It has a high mortality rate, with 4,900 dying each year.

Half of these cases are connected to human papillomaviruses (HPV), very common bugs spread through skin-to-skin contact and sex.

Following studies linking weight loss injections to improved cancer survival, researchers from Duke University School of Medicine turned their focus to head and neck squamous cell carcinoma.

Metformin, a diabetes medication, has previously been shown to reduce the risk of death from head and neck cancer, as well as other forms of the disease.

So, researchers looked at whether GLP-1s – also used to treat type 2 diabetes as well as obesity – may have similar protective effects.

They looked through the data of 4,532 patients diagnosed with head and neck cancer, who had used weight loss injections within six months of their diagnosis.

Squamous cell carcinoma of the tongue showing a malignant tumor and ulcer.
Head and neck cancer includes tumours in the mouth, throat, voice box and salivary glands Source: Getty

Symptoms of head and neck cancers

Head and neck cancer is a general term used to describe cancers that start in the:

  • Mouth, tongue or inside the nose
  • Throat (oropharynx, hypopharynx and nasopharynx)
  • Larynx – also called the voice box
  • Salivary glands

If you notice any of the following newly-developed symptoms, and you’ve had them for over three weeks, speak to your GP:

They were compared to people with cancer who hadn’t used GLP-1s, and a third group of patients who’d used the injections as well as metformin.

In the study, published to JAMA Otolaryngology–Head & Neck Surgery, GLP-1 use was linked to “significantly improved overall survival” in patients with head and neck cancer.

Specifically, weight loss jab users had a 58 per cent lower risk of death one year after diagnosis, compared to those not on the drugs.

At three years, their risk of death was 52 per cent lower and at five it was 49 per cent lower.

This was broadly the same wherever the cancer was located.

People with mouth cancer had a 40 per cent lower risk of death at the five-year mark if they used GLP-1s.

For oropharynx cancer – in the middle part of the throat – this was 49 per cent and for voice box cancer 51 per cent.

Patients who took a GLP-1 medication alongside metformin had even better outcomes – with a 71 per cent lower risk of death at one year, 64 per cent at three years, and 61 per cent at five years.

Meanwhile, metformin alone lowered the risk of death from head and neck cancer by 15 to 17 per cent.

“This study addressed a knowledge gap in treating patients with head and neck cancer in the era of widespread GLP-1 use.

“Growing evidence across several solid organ cancers has suggested that GLP-1s may exert anti-inflammatory and antiangiogenic [stopping or reducing the growth of new blood vessels] effects and suppress proinflammatory cytokine pathways.”

The drugs may also boost the immune system by boosting T cell and natural killer cells activity, researchers added, while reducing weight, blood sugar and inflammation – all of which can lower someone’s risk of cancer.

Researchers said their results are significant as they suggest GLP-1 use may be safe for people with head and neck cancer – but they note more research is needed to confirm this.

It follows research in May, which linked weight loss jabs to better odds against breast cancer.

Leave a Comment